Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax with R-CHOP or G-CHOP in B-Cell NHL and DLBCL
NCT02055820Phase 2Completed
- Sponsor
- Roche
- Start
- Nov 2013
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of venetoclax in diffuse large B-cell lymphoma (DLBCL), B-cell non-Hodgkin lymphoma, sponsored by Roche. Started Nov 2013; status: completed.
02
Drugs
venetoclax
03
Conditions
diffuse large B-cell lymphoma (DLBCL)B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT02055820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02055820.